Wahi a ka hōʻike, ua kūʻai ʻia ka mākeke kiʻiʻoniʻoni waha i ka USD 2.6 biliona i ka makahiki 2019. ʻO ka nui o ka ulu ʻana o ka makahiki mai 2020 a 2030 e manaʻo ʻia ma kahi o 9%. ʻO ka piʻi ʻana o ka noi no nā ʻōnaehana lawe lāʻau kiʻiʻoniʻoni lahilahi, R&D nui, a me nā kuʻikahi hoʻolālā ma waena o nā mea nona ka ʻenehana hou a me nā hui lāʻau lapaʻau nui nā kumu nui i manaʻo ʻia e alakaʻi i ka mākeke kiʻiʻoniʻoni waha waha i ka wā wānana. no ka mahele nui o ka mākeke kiʻiʻoniʻoni waha honua ma 2019 ma muli o ke kiʻekiʻe kiʻekiʻe o ka ʻenehana kiʻiʻoniʻoni waha a hoʻonui i ka manaʻo i nā huahana hou e hoʻokuʻu ʻia e nā mea pāʻani o ka ʻāina.
Manaʻo ʻia ka mākeke kiʻiʻoniʻoni waha ma ʻEulopa e ulu i kahi CAGR kiʻekiʻe o 11.2% mai 2020 a 2030 ma muli o ka hoʻonui ʻana o ka nui o nā poʻe maʻi maʻi e loaʻa ana i ka dysphagia a me ka hoʻonui ʻana i nā kiʻiʻoniʻoni waha i ka ʻāina.
Ke piʻi nei ka noi no nā ʻōnaehana lawe lāʻau lahilahi ma muli o nā pono e like me ka nui o ka ʻili, ka hāʻawi ʻana i ka lāʻau pololei, a me ke kala ʻoluʻolu a me ka ʻono ma mua o nā ʻōnaehana lawe lāʻau maʻamau. nā kauka lapaʻau no ka mea ʻoi aku ka maikaʻi o ka hoʻomanawanui a hāʻawi i nā hopena kiʻekiʻe. ʻO nā lāʻau kiʻiʻoniʻoni waha e hāʻawi i ka mālama hoʻomanawanui kiʻekiʻe a maʻalahi ka mālama ʻana a me ka lawe ʻana. ʻOi aku ka maikaʻi o nā ʻōnaehana lawe lāʻau kiʻi ʻoniʻoni.
Ma ka ʻōlelo o ka huahana, ua māhele ʻia ka mākeke kiʻiʻoniʻoni waha honua i loko o ke kiʻiʻoniʻoni sublingual, kiʻiʻoniʻoni waha koke, a me ka kiʻiʻoniʻoni buccal. nā hana noiʻi, ka pipeline huahana ikaika, a me ka hoʻohana ʻana i ka mākeke kiʻekiʻe o nā kiʻiʻoniʻoni sublingual e manaʻo ʻia e alakaʻi i ka ʻāpana i ka wā wānana.
I nā ʻōlelo o nā hōʻailona, ua māhele ʻia ka mākeke kiʻiʻoniʻoni waha honua i ka hoʻokele ʻeha, nā maʻi neurological, nausea a me ka luaʻi, ka hilinaʻi opioid, a me nā mea ʻē aʻe. ʻO nā maʻi neurological e manaʻoʻia e hoʻokele i ka māhele ma luna o ka wā wānana.ʻO ka maʻamau o nā maʻi neurological ma India e pili ana i 2,394 no 100,000 poʻe, e like me kaʻikepili i paʻiʻia e ka National Center for Biotechnology Information.
Hoʻokumu ʻia i ke kahawai hoʻolaha, ua hoʻokaʻawale ʻia ka mākeke kiʻiʻoniʻoni waha honua i nā lāʻau lapaʻau halemai, nā hale kūʻai hale kūʻai, a me nā lāʻau lapaʻau pūnaewele. hale kūʻai lāʻau lapaʻau ma nā ʻāina ulu.
I nā ʻōlelo o nā wahi, ua māhele ʻia ka mākeke kiʻiʻoniʻoni waha honua i ʻAmelika ʻAmelika, ʻEulopa, ʻAmelika ʻAmelika, Asia Pacific, a me ka Middle East & Africa. wānana manawa. ʻO ke komo kiʻekiʻe o nā kiʻiʻoniʻoni waha, ka loaʻa ʻana o ka huahana, a me ka loaʻa ʻana o ka nui o nā mea hoʻolako ʻo ia nā kumu nui e alakaʻi nei i ka mākeke ma kēia wahi i hoʻohālikelike ʻia me nā wahi ʻē aʻe. i ka wā e hiki mai ana i ka hiki ʻana mai o nā mea pāʻani kūloko a me ka honua a me ka hoʻonui ʻana i ka noi no nā kiʻiʻoniʻoni waha ma ka ʻāina. ʻO ka hele ʻana o ka nui o ka poʻe maʻi maʻi geriatric me ka dysphagia i kēia mau ʻāina i hui pū ʻia me ka hoʻonui ʻana i ka mālama olakino e manaʻo ʻia e hoʻokele i ka mākeke ma Asia Pacific i nā makahiki e hiki mai ana.
ʻO nā mea pāʻani nui e hana ana i ka mākeke kiʻiʻoniʻoni waha honua ʻo ZIM Laboratories Limited, Indivior plc, Aquestive Therapeutics, Inc., LIVKON Pharmaceuticals pvt.Ltd, Shilpa Therapeutics Pvt.Ltd, Sunovion Pharmaceuticals, Inc., NAL Pharma, Cure Pharmaceutical, IntelGenx Corp. ., Dr. Reddy's Laboratories, Kyu Pharmaceutical Co Ltd, Seoul PharmaCo a me CL Pharm. Ke komo nei kēia mau hui i ka noiʻi a me ka hoʻomohala ʻana e hoʻomohala i nā huahana hou e hoʻonui i nā makana huahana a me ka custo.
Ka manawa hoʻouna: Mei-16-2022